HRA Pharma’s former CEO David Wright joins Ceuta Group

Ceuta Group, a global brand building business providing end-to-end outsourcing services in the health and wellness industry has appointed David Wright as a
non-executive board director.

With extensive experience of leading global consumer healthcare companies, David joins Ceuta Group following five years as CEO/President of global pharmaceutical
company, HRA Pharma and six years as Global Head of Boehringer Ingelheim’s consumer business.

During his time at HRA Pharma and Boehringer Ingelheim GmBH, David led both companies through substantial organisational and strategy re-design which led to
sustainable growth and profitability.

The company said: “David has a strong belief that combining the right structure, operational priorities and processes, with a strong focus on company culture, are
critical factors in building successful businesses. This approach saw him lead a period of transformation at HRA Pharma resulting in the company’s successful
acquisition by Perrigo Company plc.”

David will take an active role on the Ceuta Group Board supporting and building the company’s strategic vision and priorities. He will also help shape the company’s
growth plans on an operational level to ensure Ceuta Group continues to meet client’s needs today and into the future.